Unknown

Dataset Information

0

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.


ABSTRACT: S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation, and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-?1, supporting a non-canonical role of S100A4 in pancreatic cancer. The role of S100A4 in tumor progression was studied by using an orthotopic human pancreatic cancer xenograft mouse model. Tumor mass is remarkably decreased in animals injected with S100A4-deficient pancreatic tumor cells. P27(Kip1) expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in S100A4-deficient pancreatic tumors in vivo. S100A4-deficient tumors have lower expression of vascular endothelial growth factor, suggesting reduced angiogenesis. Biochemical assays revealed that S100A4 activates Src and focal adhesion kinase (FAK) signaling events, and inhibition of both kinases is required to maximally block the tumorigenic potential of pancreatic cancer cells. These findings support that S100A4 plays an important role in pancreatic cancer progression in vivo and S100A4 promotes tumorigenic phenotypes of pancreatic cancer cells through the Src-FAK mediated dual signaling pathway.

SUBMITTER: Che P 

PROVIDER: S-EPMC4326725 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.

Che Pulin P   Yang Youfeng Y   Han Xiaosi X   Hu Meng M   Sellers Jeffery C JC   Londono-Joshi Angelina I AI   Cai Guo-Qiang GQ   Buchsbaum Donald J DJ   Christein John D JD   Tang Qinjiu Q   Chen Dongquan D   Li Qianjun Q   Grizzle William E WE   Lu Yin Ying YY   Ding Qiang Q  

Scientific reports 20150213


S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation, and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-β1, supporting a non-canonical role of S100A4 in pancreatic cancer. The rol  ...[more]

Similar Datasets

| S-EPMC3332079 | biostudies-literature
| S-EPMC4683442 | biostudies-literature
| S-EPMC11231845 | biostudies-literature
| S-EPMC3064514 | biostudies-literature
| S-EPMC1489135 | biostudies-literature
| S-EPMC6519306 | biostudies-literature
| S-EPMC3911518 | biostudies-literature
2013-09-17 | GSE43873 | GEO
2013-09-17 | E-GEOD-43873 | biostudies-arrayexpress
2018-12-01 | GSE123182 | GEO